|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.54 HKD | 0.00% |
|
+1.20% | +2.01% |
Essex Bio-Technology Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was HKD 1,637.66 million compared to HKD 978.11 million a year ago. Net income was HKD 345.97 million compared to HKD 218.93 million a year ago.
Basic earnings per share from continuing operations was HKD 0.6 compared to HKD 0.3788 a year ago. Diluted earnings per share from continuing operations was HKD 0.5813 compared to HKD 0.3728 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.01% | 18Cr | |
| -1.62% | 8.92TCr | |
| +1.32% | 4.05TCr | |
| -15.83% | 3.28TCr | |
| +64.13% | 2.62TCr | |
| -21.44% | 1.45TCr | |
| -7.92% | 1.31TCr | |
| -44.07% | 1.16TCr | |
| -13.06% | 1.15TCr | |
| +4.94% | 881.83Cr |
ESSEX BIO-TECHNOLOGY LIMITED 
